Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
35,872,648
-
Total 13F shares
-
20,716,453
-
Share change
-
+490,109
-
Total reported value
-
$85,559,282
-
Price per share
-
$4.13
-
Number of holders
-
81
-
Value change
-
+$3,327,577
-
Number of buys
-
55
-
Number of sells
-
17
Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q2 2025
As of 30 Jun 2025,
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,716,453 shares.
The largest 10 holders included
AH CAPITAL MANAGEMENT, L.L.C., Sofinnova Investments, Inc., Cormorant Asset Management, LP, ADAR1 Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., ORBIMED ADVISORS LLC, Sands Capital Alternatives, LLC, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.